Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda

Population Pharmacokinetics of Dihydroartemisinin and Piperaquine in Pregnant and Nonpregnant Women with Uncomplicated Malaria

(2012) Joel Tarning et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Prediction-Corrected Visual Predictive Checks for Diagnosing Nonlinear Mixed-Effects Models

(2011) Martin Bergstrand et al.   AAPS Journal

Population Pharmacokinetics of Artemether, Lumefantrine, and Their Respective Metabolites in Papua New Guinean Children with Uncomplicated Malaria

(2011) Sam Salman et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Lower atovaquone/proguanil concentrations in patients taking efavirenz, lopinavir/ritonavir or atazanavir/ritonavir

(2010) Matthijs Van Luin et al.   AIDS

Population Pharmacokinetics and Pharmacodynamics of Artemether and Lumefantrine during Combination Treatment in Children with Uncomplicated Falciparum Malaria in Tanzania

(2010) S. F. Hietala et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Artemisinin combination therapy for vivax malaria

(2010) Nicholas M Douglas et al.   LANCET INFECTIOUS DISEASES

Efficacy and safety of artemether–lumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: an open-label, randomised, non-inferiority trial

(2010) Patrice Piola et al.   LANCET INFECTIOUS DISEASES

Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine

(2010) Shabana Ali et al.   MALARIA JOURNAL

Quantifying the Number of Pregnancies at Risk of Malaria in 2007: A Demographic Study

(2010) Stephanie Dellicour et al.   PLOS MEDICINE

Handling Data Below the Limit of Quantification in Mixed Effect Models

(2009) Martin Bergstrand et al.   AAPS Journal

Importance of Shrinkage in Empirical Bayes Estimates for Diagnostics: Problems and Solutions

(2009) Radojka M. Savic et al.   AAPS Journal

Population Pharmacokinetics of Lumefantrine in Pregnant Women Treated with Artemether-Lumefantrine for Uncomplicated Plasmodium falciparum Malaria

(2009) J. Tarning et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacokinetic Properties of Sulfadoxine-Pyrimethamine in Pregnant Women

(2009) H. A. Karunajeewa et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacokinetics of Sulfadoxine and Pyrimethamine in Intermittent Preventive Treatment of Malaria in Pregnancy

(2009) M M Nyunt et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Variation of Drug Kinetics in Pregnancy

(2009) Petr Pavek et al.   CURRENT DRUG METABOLISM

Efficacy and safety of a fixed dose artesunate-sulphamethoxypyrazine-pyrimethamine compared to artemether-lumefantrine for the treatment of uncomplicated falciparum malaria across Africa: a randomized multi-centre trial

(2009) Issaka Sagara et al.   MALARIA JOURNAL

A liquid chromatographic–tandem mass spectrometric method for determination of artemether and its metabolite dihydroartemisinin in human plasma

(2009) Warunee Hanpithakpong et al.   Bioanalysis

Likelihood based approaches to handling data below the quantification limit using NONMEM VI

(2008) Jae Eun Ahn et al.   JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS

Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial

(2008) Salim Abdulla et al.   LANCET

A Randomised Controlled Trial of Artemether-Lumefantrine Versus Artesunate for Uncomplicated Plasmodium falciparum Treatment in Pregnancy

(2008) Rose McGready et al.   PLOS MEDICINE